CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Fund of Fortnight

Fund of Fortnight

MF Select- This is our mutual fund recommendation. Every fortnight , we recommend one open-ended equity diversified fund that has the best potential of returns for the next one year considering its constituents remain the same.

Invesco India Mid Cap Fund - Direct Plan (Growth)



Reason for recommendation

The midcap index has been underperforming large cap funds for a while now. However, in the last three months, we see that the midcap index has started outperforming the largecap index. In the last one-month and three-month period, the Sensex has moved up by 2.42 per cent and 10.05 per cent, respectively. While the BSE Midcap has generated a respective return of 3.3 per cent and 13.14 per cent in the same period. It looks sustainable and, hence, makes sense to be the part of this growth.Invesco India midcap fund is one such fund from the midcap category that will help investors gain from the rise in midcap. At the end of October 2019, almost 68 per cent of the total corpus of the fund has been invested in midcap stocks 15 per cent is invested in smallcap and 12 per cent in largecap stocks. The best part of the fund is that it has been performing in both rising as well as falling markets. For example, in 2018, the fund was able to arrest its fall to 5.27 per cent compared to the average category fall of 11.91 per cent. In 2017, when the market was moving up unidirectional the fund generated 44.32 per cent of return compared to 42.47 per cent by the category average. The fund follows a bottom-up approach to portfolio construction and remains sector agnostic. It concentrates on quality companies with higher return ratios along with healthy cash flows. In terms of growth and value, the fund is more tilted towards growth. The fund is well-diversified, with 42 stocks and has been overweight on Healthcare and Energy. In terms of stock, the fund seems to bet on momentum stocks, such as ICICI Bank, Cholamandalam Investment & Finance Company, and Sanofi. These stocks are likely to perform better going ahead. The fund is suited for risk-taking investors with an investment horizon of a minimum of three years.

Previous Article Ten stocks close to their 52-week low
Next Article MF Query Board
Print
1369 Rate this article:
No rating
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR